JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL revenue breakdown overview

JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL revenue for the last year amounted to 1.03 B CNY, the most of which — 1.03 B CNY — came from its highest performing source at the moment, Pharmaceutical Manufacturing, the year earlier bringing 651.29 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL 585.29 M CNY, and the year before that — 283.86 M CNY.